Directory
Luis Brieva Ruiz

Luis Brieva Ruiz

Degree: PhD

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3812-2011

Groups

Publications

  • Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, JR; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, L; Eichau, S; García-Merino, JA; Garcia-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Ginés, M; Meca-Lallana, JE; Prieto, JM; Rodríguez-Antigüedad, A; Tintoré, M; Blanco, Y; Moral, E

    Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement

    NEUROLOGIA 36 50-60. .

    [doi:10.1016/j.nrl.2020.02.006]

  • Casado V.; Bonaventura I.; Brieva L.; Martínez-Yélamos S.; Martín G.; Presas-Rodriguez S.; Hervas M.; Hernández J.J.; Munteis E.; Escartin A.; Gubieras L.; Mañé-Martínez M.A.; Ramió-Torrentà L.

    Costes directos de los brotes en pacientes con esclerosis múltiple remitente-recurrente

    Neurology Perspectives 1 160-169. .

    [doi:10.1016/j.neurop.2021.05.003]

  • Meca-Lallana, J. E.; Fernandez-Prada, M.; Garcia Vazquez, E.; Moreno Guillen, S.; Otero Romero, S.; Rus Hidalgo, M.; Villar Guimerans, L. M.; Eichau Madueño S; Fernandez Fernandez, O.; Izquierdo Ayuso, G.; Álvarez Cermeño JC; Arnal Garcia, C.; Arroyo Gonzalez, R.; Brieva Ruiz, L.; Calles Hernandez, C.; Garcia Merino, A.; Gonzalez Platas, M.; Hernandez Perez, M. A.; Moral Torres, E.; Olascoaga Urtaza, J.; Oliva-Nacarino, P.; Oreja-Guevara, C.; Ortiz Castillo, R.; Oterino, A.; Prieto Gonzalez, J. M.; Ramio-Torrenta, L.; Rodriguez-Antiguedad, A.; Saiz, A.; Tintore, M.; Montalban Gairin, X.

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    NEUROLOGIA 37 615-630. .

    [doi:10.1016/j.nrl.2019.11.003]

  • Meca-Lallana, J; Maurino, J; Hernández-Pérez MÁ; Sempere, AP; Brieva, L; García-Arcelay E; Terzaghi, M; Saposnik, G; Ballesteros, J

    Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.

    Neurology and Therapy 9 173-179. .

    [doi:10.1007/s40120-020-00176-6]

  • Vazquez-Justes, D; Carreño-Gago L; Garcia-Arum, E; Traveset, A; Montoya, J; Ruiz-Pesini, E; Lopez, R; Brieva, L

    Mitochondrial m.13513G > A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing

    Journal of Pediatric Genetics 8 231-234. .

    [doi:10.1055/s-0039-1691812]

  • Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L

    Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients

    Frontiers in Neuroscience 13 938-938. .

    [doi:10.3389/fnins.2019.00938]

  • Nogueras, L; Gonzalo, H; Jove, M; Sol, J; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Solana, MJ; Peralta, S; Pamplona, R; Brieva, L

    Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

    SCIENTIFIC REPORTS 9 11313-11313. .

    [doi:10.1038/s41598-019-47906-x]

  • Oreja-Guevara, C; Ayuso Blanco T; Brieva Ruiz L; Hernández Pérez MÁ; Meca-Lallana, V; Ramió-Torrentà L

    Cognitive Dysfunctions and Assessments in Multiple Sclerosis

    Frontiers in Neurology 10 581-581. .

    [doi:10.3389/fneur.2019.00581]

  • Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II)

    REVISTA DE NEUROLOGIA 68 468-479. .

    [doi:10.33588/rn.6811.2019121]

  • Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)

    REVISTA DE NEUROLOGIA 68 431-441. .

    [doi:10.33588/rn.6810.2019120]

  • Hervas-Garcia, JV; Ramio-Torrenta, L; Brieva-Ruiz, L; Batlle-Nadal, J; Moral, E; Blanco, Y; Cano-Orgaz, A; Presas-Rodriguez, S; Torres, F; Capellades, J; Ramo-Tello, C

    Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial

    EUROPEAN JOURNAL OF NEUROLOGY 26 525-532. .

    [doi:10.1111/ene.13851]

  • González Mingot C; Juárez Turégano A; Bosch Gaya A; Brieva Ruiz L

    Cardiogenic shock in clinically isolated syndrome

    NEUROLOGIA 34 69-72. .

    [doi:10.1016/j.nrl.2017.03.008]

Projects

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO